Babao, Darwin, Jr. C.

HRN: 27-91-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
AMPICILLIN 250MG (VIAL)
10/04/2025
10/11/2025
IV DRIP
90mg
Q12h
PSNB
Waiting Final Action 
10/04/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
10/04/2025
10/11/2025
IV DRIP
9mg
Q24h
PSNB
Waiting Final Action 
10/05/2025
CEFOTAXIME 500MG (VIAL)
10/05/2025
10/11/2025
IV
90mg
Q12
PSNB
Waiting Final Action 
10/15/2025
CEFTAZIDIME 1GM (VIAL)
10/15/2025
10/22/2025
IV DRIP
92mg
Q12h
Sepsis
Waiting Final Action 
10/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/18/2025
10/25/2025
IV
180mg
Q8
SEPSIS
Waiting Final Action 
10/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/18/2025
10/25/2025
IV
25mg
Q24
SEPSIS
Waiting Final Action 
10/19/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/19/2025
10/26/2025
IV
22mg LD, 11mg MD
Q 24
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: